Burning Rock Biotech Ltd (BNR) Actualités

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Burning Rock Announces Results of 2024 Annual General Meeting

GUANGZHOU, China, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company”...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Burning Rock Reports Third Quarter 2024 Financial Results

GUANGZHOU, China, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company”...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Burning Rock Announces 2024 Annual General Meeting to be Held on December 31, 2024

GUANGZHOU, China, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company”...

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China

GUANGZHOU, China, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company”...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Burning Rock Announces Changes to Management and Board of Directors

GUANGZHOU, China, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR) (the...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]